De Novo device
MagDI System (MAG-02, DS-01)
Gt Metabolic Solutions, Inc. · Magnetic Compression Anastomosis System (SAH, Class II) · First FDA decision Jul 2, 2024, newest Feb 28, 2025Obesity
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
De Novo pathway
Device trials
6
Naming "MagDI"
MAUDE reports
0
Brand "MagDI", since 2015
PubMed studies
26
Mentioning "MagDI"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing MagDI System (MAG-02, DS-01)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K243359 · Decided Feb 28, 2025 · 122 days after receipt
Device type: Magnetic Compression Anastomosis System (SAH) · General & Plastic Surgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "MagDI", any status and sponsor, newest update first.
- MagDI Australia StudyCompleted
GT Metabolic Solutions, Inc.Not on our public-company list
NCT06473831 · 25 participants · Start Aug 13, 2024 · Primary completion Sep 4, 2025
Device: Magnet System, DI Biofragmentable · For: Obesity; Type 2 Diabetes
Sites: Sydney, Australia; Murdoch, Australia; Adelaide, Australia · 4 sites in all
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MagDI", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code SAH
1 reports: 0 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "MagDI"[tiab]. The summary above synthesizes these.
- Side-to-side magnetic duodeno-ileostomy in adults with severe obesity with or without type 2 diabetes: early outcomes with prior or concurrent sleeve gastrectomy.
Gagner M, Almutlaq L, Cadiere GB, et al. · Surg Obes Relat Dis · 2024Multicenter Study
- Magnetic single-anastomosis side-to-side duodeno-ileostomy for revision of sleeve gastrectomy in adults with severe obesity: 1-year outcomes.
Gagner M, Almutlaq L, Gnanhoue G, et al. · World J Surg · 2024Research Support, Non-U.S. Gov't
- Professor Sir Magdi Yacoub and the Aswan Heart Centre.
Scholtz A · J Am Coll Cardiol · 2018Editorial
- Magnetic Duodeno-Ileostomy as a Conversion Procedure After Sleeve Gastrectomy: First Single-Centre Experience in Colombia.
Nassar R, Giron F, Visbal-Zuluaga M, et al. · Obes Surg · 2026
- From the heart.
Nurs Stand · 2001
- Sir Magdi Yacoub.
Billimoria AR · J Assoc Physicians India · 2013Biography, Historical Article
- Sir Magdi H. Yacoub, the Leonardo da Vinci of cardiac surgery.
Alivizatos PA · Proc (Bayl Univ Med Cent) · 2019
- First-in-Human Side-to-Side Duodenoileal Bipartition for Weight Loss and Type 2 Diabetes with the Swallowable Biofragmentable Magnetic Anastomosis System.
Gagner M, Abuladze D, Buchwald J, et al. · J Am Coll Surg · 2025
- Magdi Yacoub: a lifelong affair with the heart.
Watts G · Lancet · 2016Biography, Historical Article
- Valve-sparing aortic root replacement.
Sin YK, Pillai RG · J Card Surg · 2000
- Surgical remodeling of left ventricle.
Dor V · Surg Clin North Am · 2004Comparative Study, Review
- Magdi Yacoub: a surgeon and a scientist.
Bonn D · Lancet · 2000Biography, Historical Article
Other devices of this type
Also filed under product code SAH.
- Self-Forming Magnet (Flexagon Plus OTOLoc)GI Windows, Inc. · 510(k) 2026
- GI Windows Flexagon Plus OTOLoc SystemGI Windows Surgical · 510(k) 2026
- GT Metabolic Magnet System (MAG-04Gt Metabolic Solutions, Inc. · 510(k) 2026
- GT Metabolic MagDI System (MAG-01, MAG-02, DS-01)Gt Metabolic Solutions, Inc. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.